Responses
Urology
Protocol
Add-on or switch to vibegron in patients with overactive bladder insufficiently responding to initial 4-week antimuscarinics: a randomised, parallel-group, multicentre trial (ADVISR) protocol
Compose a Response to This Article
Other responses
No responses have been published for this article.